Pinedo-Lechuga M, Rodríguez-Lopez D

Language: Spanish
References: 16
Page: 354-356
PDF size: 156.11 Kb.

ABSTRACT

Rhabdomyolysis is a clinical entity characterized by the destruction of skeletal muscle with the resulting release of intracellular enzyme content into the blood circulation that can lead to systemic complications, including kidney failure as one of the most serious. The causes described are excessive exercise, trauma, medications and drugs, to infectious diseases such as viral pneumonia. Coronavirus disease 2019 is a public health emergency. Patients with SARS-CoV-2 infection mainly present with fever, cough, and dyspnea. This symptomatology can evolve into a picture of severe respiratory distress and severe pneumonia. In addition, extrapulmonary systemic manifestations have been reported, including its association with rhabdomyolysis.

REFERENCES

1. Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis-an overview for clinicians. Crit Care. 2005;9(2):158-169.

2. Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: Pathophysiology and diagnosis. Eur J Intern Med. 2007;19(2):90-100.

3. Bagley WH, Yang H, Shah KH. Rhabdomyolysis. Intern Emerg Med. 2007;2(3):210-218.

4. Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care. 2016;20(1):135.

5. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62-72.

6. Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA. The COVID-19 pandemic: a comprehensive re- view of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. J Clin Med. 2020;9(4): 1225.

7. Berlin D, Gulick R, Martinez F. Severe Covid-19. N Engl J Med. 2020; 383:2451-2460.

8. Li RL, Chu SG, Luo Y, Huang ZH, Hao Y, Fan CH. Atypical presentation of SARS-CoV-2 infection: A case report. World J Clin Cases. 2020;8(7):1265-1270.

9. Fadila M, Wool K. Rhabdomyolysis secondary to influenza a infection: A case report and review of the literature. N Am J Med Sci. 2015;7(3):122.

10. Subirá González A, Fernández Morales M, Sánchez Royo E, Boliart de San Félix Y, Vila Lolo C. Propofol infusion syndrome; are high doses always required? Rev Esp Anestesiol Reanim (Engl Ed). 2020;67(3):163-166.

11. Tanaka T, Takada T, Takagi D, Takeyama N, Kitazawa Y. Acute renal failure due to rhabdomyolysis associated with echovirus 9 infection: A case report and review of literature. Jpn J Med. 1989;28:237-242.

12. Lundberg A. Myalgia cruris epidemica. Acta Paediatr. 1957;46(1):18-31.

13. Parikh M, Dolson G, Ramanathan V, Sangsiraprapha W. Novel H1N1-associated rhabdomyolysis leading to acute renal failure. Clin Microbiol Infect. 2010;16(4):330-332.

14. Sinha P, Matthay M, Calfee C. Is a "Cytokine Storm" Relevant to COVID-19? JAMA Intern Med. 2020;180(9):1152-1154.

15. Jin M, Tong Q. Rhabdomyolysis as Potential Late Complication Associated with COVID-19. Emerg Infect Dis. 2020;26(7):1618-1620. Available in: https://dx.doi.org/10.3201/eid2607.200445

16. Borku Uysal B, Ikitimur H, Yavuzer S, Islamoglu M, Cengiz M. Case Report: A COVID-19 Patient Presenting with Mild Rhabdomyolysis. Am J Trop Med Hyg. 2020;103(2):847-850.